Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Dina Zipin has 10+ years of experience as a writer and editor and 2+ years as the head writer/creative strategist for Uproxx Media. Suzanne is a content marketer, writer, and fact-checker. She holds a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results